Here’s Why AstraZeneca, The World’s Leading Vaccine Candidate, Stopped The Human Trials

Kartik Nijhawan

India has become the second-worst hit country by the coronavirus, recently after the total number of cases surpassed total number of cases of Brazil. The end of the pandemic is nowhere in sight and now we have started hearing about reinfections cases as well. 

www.pexels.com

Some countries are focusing on vaccine development and some are focusing on buying it from other countries even before the development is confirmed. Something we call Vaccine nationalism. 

Russia and China have already claimed that they have vaccines for coronavirus.  

www.pexels.com

On the other hand, the world’s leading vaccine candidate being developed by Oxford University and AstraZeneca have halted its clinical trials worldwide after one of the participants reported serious unknown side effects. 

www.abc.net.au

Shahid Jameel, a virologist told The Indian Express:

This is nothing to be alarmed about as of now. These things happen quite routinely during vaccine or drug trials. The good thing is that despite the rush to produce a coronavirus vaccine, we still have systems in place that would pick these things out. So that is reassuring.

He further said:

When such things emerge, you have to pause, reassess, re-examine. And that is what seems to be happening in this case. This is normal process, and this is how it should be.

This vaccine was considered to be the most promising one and has already sold more than 1 billion doses, even before the human trials ended. 

You might also like
This Influencer Took A Sex Worker Out For Sushi, And The Internet Can’t Stop Cheering For Him
12 Viral Slangs From 2024 That’ll Tell If You’re Gen Z’s Internet Royalty Or Just Cheugy
From Bado Badi to Chill Guy, The Internet Was Unhinged In 2024 & We Loved It
Mumbai Man’s Humiliating Experience At Bryan Adams Concert Exposes Poor Event Planning
Gurgaon Redditor Shares Chilling Uber Driver Message & The Internet Is Equally Confused & Spooked
Paneer Makhani For ₹2,900? Twitter Wants To Know If It Was Made With Gold